TMP-153, a novel ACAT inhibitor, inhibits cholesterol absorption and lowers plasma cholesterol in rats and hamsters
- 1 February 1995
- journal article
- Published by Elsevier in Atherosclerosis
- Vol. 113 (1) , 71-78
- https://doi.org/10.1016/0021-9150(94)05429-m
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Novel Acyl-CoA:Cholesterol Acyltransferase Inhibitors. Synthesis and Biological Activity of 3-Quinolylurea DerivativesJournal of Medicinal Chemistry, 1994
- Effect of the ACAT inhibitor CI-976 on plasma cholesterol concentrations and distribution in hamsters fed zero- and low-cholesterol dietsClinical Biochemistry, 1992
- U-73482: A novel ACAT inhibitor that elevates HDL-cholesterol, lowers plasma triglyceride and facilitates hepatic cholesterol mobilization in the ratAtherosclerosis, 1992
- Therapeutic potential of ACAT inhibitors as lipid lowering and anti-atherosclerotic agentsTrends in Pharmacological Sciences, 1991
- Cholesterol is required for the secretion of the very-low-density lipoprotein: in vivo studiesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1990
- On the mechanism by which an ACAT inhibitor (CL 277,082) influences plasma lipoproteins in the ratAtherosclerosis, 1990
- Pharmacological approaches to the modulation of plasma cholesterolTrends in Pharmacological Sciences, 1988
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987
- Receptor-mediated transport of cholesterol between cultured cells and high-density lipoproteinsPublished by Elsevier ,1986
- The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart diseaseJAMA, 1984